The NR3C2 gene gives your body instructions for a receptor that lets aldosterone tell the kidneys to keep salt and water and remove extra potassium. This gene plays an important role in keeping blood pressure, fluid balance, and potassium levels within a healthy range. If it does not work well, especially in babies, the body can lose too much salt in urine, which may lead to dehydration, low blood pressure, poor feeding, and high potassium. Pathogenic variants in the NR3C2 gene are linked to a form of pseudohypoaldosteronism type 1.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes take place, where they occur, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed explanation of this topic, you can learn more in LearnHub.
Overview
NR3C2Gene function
What if the gene works
The NR3C2 gene helps your body respond to aldosterone, a hormone that balances salt and water. This supports healthy blood pressure and helps the kidneys control sodium and potassium levels.
Risk
What if the gene does not work
Variants in the NR3C2 gene can cause the kidney form of pseudohypoaldosteronism type 1, with salt loss, dehydration, and high potassium in infancy. Milder and more severe variants can affect onset and severity, and many improve with age.
Treatment
What does that mean for your treatment
With a pathogenic loss-of-function variant in the NR3C2 gene, treatment usually centers on salt replacement and managing high potassium, especially in infancy. Medicines that mimic aldosterone, such as fludrocortisone, generally do not help because the body’s mineralocorticoid response is reduced. Many people need the most support early in life, and treatment often becomes less intensive with age.
Conditions associated with NR3C2
Gene function
What if the gene works
Your kidneys use the NR3C2 gene to respond to aldosterone, a hormone that guides salt and water balance. A key part of NR3C2 gene function in the kidney is helping certain cells switch on the right instructions at the right time. This supports healthy fluid levels, potassium balance, and day to day blood pressure control.
Its protein receives aldosterone signals inside certain cells. After that signal arrives, it helps switch specific genes on or off so the cell can adjust its work.
In the kidneys, the NR3C2 gene helps cells hold on to the right amount of sodium. This supports the body’s fluid balance and helps blood pressure stay steadier through the day.
The NR3C2 gene also helps kidney cells move extra potassium into urine. Keeping potassium in range supports normal muscle and nerve activity, including the heartbeat.
This gene also helps regulate salt movement in the colon, sweat glands, and salivary glands. That fine tuning supports everyday balance of fluids and minerals across the body.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body reacts to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NR3C2 gene can weaken or switch off the mineralocorticoid receptor by changing its shape, reducing its stability, or stopping it from reaching the cell nucleus and controlling the right genes. This explains how NR3C2 gene variants affect receptor function at a cellular level. Milder variants may leave some signaling intact, while more severe variants can cause little or no receptor activity and are often linked to earlier or more noticeable features of renal pseudohypoaldosteronism type 1.
How variants are linked to conditions
Pathogenic variants in the NR3C2 gene cause the renal form of pseudohypoaldosteronism type 1, so an NR3C2 gene variant linked to pseudohypoaldosteronism type 1 can confirm this diagnosis. This condition usually appears in infancy and is associated with salt loss, dehydration, low sodium, and high potassium. Symptoms often improve with age, though some people continue to need monitoring.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, one well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For NR3C2, risk is mostly shaped by whether you were born with a disease-causing gene change, and it can run in families. In people living with an NR3C2-related condition, salt loss and related problems can become more noticeable during infancy or during illness, vomiting, diarrhea, or dehydration.
Inheritance of NR3C2 variants
For families asking how NR3C2 variants are inherited, the best established pattern is autosomal dominant for NR3C2-related renal pseudohypoaldosteronism type 1. This means a parent carrying a disease-causing variant in the NR3C2 gene can pass it to a child, and each pregnancy has a 50% chance of inheriting that variant. Sons and daughters are affected in the same way because the NR3C2 gene is on chromosome 4, not a sex chromosome. In some families the variant is inherited across generations, while in others it may appear for the first time in one person.
What does my NR3C2 result mean for my family?
For NR3C2, family impact is usually discussed in the setting of a condition called renal pseudohypoaldosteronism type 1, which most often runs in families in a dominant pattern. This means close relatives, such as a parent, sibling, or child, may also have the same gene change and could have symptoms ranging from mild to more noticeable salt-loss problems, especially in infancy. Because signs can differ even within one family, some relatives may not realize they are affected.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the NR3C2 gene, doctors use genetic testing for NR3C2 variants on DNA from blood, saliva, or a cheek swab. The lab reads the gene’s code and may also check for missing or extra pieces, then compares any variant found with known clinical evidence.
When should I consider getting a genetic test?
Testing for changes in the NR3C2 gene can be worth considering when a baby or child has repeated episodes of dehydration, poor feeding, vomiting, low blood salt, and high potassium, especially if similar problems run in the family. A result may help confirm a salt-balance condition and guide family counseling.
A genetic result is only one part of your health story
How much a genetic result can tell you varies by the condition and by the type of variant involved, even though it can offer important insight. Lifestyle, environment, age, medical history, and other influences all shape how the body works over time. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others have differences in how strongly their body reacts to the same treatment. This is common and can help explain why one medicine works well for one person but less well for another. These differences may affect how much benefit a treatment gives or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. By looking at the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. Understanding this can support treatment decisions that are more informed and better tailored to the individual. You can read more about this topic in the LearnHub.
Drugs influenced by the NR3C2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how doctors choose or adjust medicines, so any concerns about treatment, side effects, blood pressure, or hormone-related symptoms are best discussed with your doctor.
History
Researchers identified the mineralocorticoid receptor during the rapid expansion of steroid hormone genetics in the 1980s. Building on this early work, scientists cloned the NR3C2 gene and mapped it to chromosome 4, which helped place it within a larger receptor family. In the 1990s, variants in the NR3C2 gene were linked to inherited forms of salt wasting, especially autosomal dominant pseudohypoaldosteronism type 1. That connection gave the gene a clear place in both endocrinology and medical genetics. Over time, descriptions became more precise as testing improved and more families were studied. Today, the NR3C2 gene is mainly known in clinical medicine for its role in inherited mineralocorticoid resistance and related research.